| 1 | [SID131281810] | Active | IC50 | 1 | Inhibition of human purified phosphomannose isomerase [AID597374, Type: Literature] | Mannose-6-phosphate isomerase [gi:462567] |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 131281810 | | CID | 25181243 | | Outcome | Active | | IC50 | 1 [uM] | | BioAssay | Inhibition of human purified phosphomannose isomerase | | AID | 597374 | | BioAssay type | Literature | | Target | Mannose-6-phosphate isomerase [gi:462567] | | PubMed | 21539312 | | Data Table |  |
|
| 2 | [SID131281810] | Active | IC50 | 1 | Inhibition of human purified phosphomannose isomerase [AID597374, Type: Literature] | Mannose-6-phosphate isomerase [gi:462567] |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 131281810 | | CID | 25181243 | | Outcome | Active | | IC50 | 1 [uM] | | BioAssay | Inhibition of human purified phosphomannose isomerase | | AID | 597374 | | BioAssay type | Literature | | Target | Mannose-6-phosphate isomerase [gi:462567] | | PubMed | 21539312 | | Data Table |  |
|
| 3 | [SID57287680] | Active | IC50 | 1.03 | Confirmation of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay. [AID1535, Type: confirmatory] | MPI protein [Homo sapiens] [gi:16878311] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 57287680 | | CID | 25181243 | | Outcome | Active | | IC50 | 1.03 [uM] | | BioAssay | Confirmation of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay. | | AID | 1535 | | BioAssay type | confirmatory | | Target | MPI protein [Homo sapiens] [gi:16878311] | | PubMed | | | Data Table |  |
|
| 4 | [SID57287680] | Active | IC50 | 1.03 | Confirmation of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay. [AID1535, Type: confirmatory] | MPI protein [Homo sapiens] [gi:16878311] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 57287680 | | CID | 25181243 | | Outcome | Active | | IC50 | 1.03 [uM] | | BioAssay | Confirmation of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay. | | AID | 1535 | | BioAssay type | confirmatory | | Target | MPI protein [Homo sapiens] [gi:16878311] | | PubMed | | | Data Table |  |
|
| 5 | [SID85147392] | Active | Potency | 2.5929 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | Potency | 2.5929 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID85147392] | Active | Potency | 2.5929 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | Potency | 2.5929 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID85147392] | Active | Potency | 2.8184 | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) [AID651820, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | Potency | 2.8184 [uM] | | BioAssay | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) | | AID | 651820 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID85147392] | Active | Potency | 2.8184 | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | Potency | 2.8184 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 9 | [SID85147392] | Active | Potency | 2.8184 | qHTS Assay for Inhibitors of GCN5L2 [AID504327, Type: confirmatory] | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | Potency | 2.8184 [uM] | | BioAssay | qHTS Assay for Inhibitors of GCN5L2 | | AID | 504327 | | BioAssay type | confirmatory | | Target | histone acetyltransferase KAT2A [Homo sapiens] [gi:153791535] | | PubMed | | | Data Table |  |
|
| 10 | [SID85147392] | Active | Potency | 3.5481 | qHTS Assay for Rab9 Promoter Activators [AID485297, Type: confirmatory] | RAB9A gene product [Homo sapiens] [gi:4759012] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | qHTS Assay for Rab9 Promoter Activators | | AID | 485297 | | BioAssay type | confirmatory | | Target | RAB9A gene product [Homo sapiens] [gi:4759012] | | PubMed | | | Data Table |  |
|
| 11 | [SID85147392] | Active | Potency | 4.1475 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | Potency | 4.1475 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID85147392] | Active | IC50 | 5.42 | Fluorescence-based cell-based high throughput dose response assay for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) [AID651553, Type: confirmatory] | RIPK2 gene product [Homo sapiens] [gi:4506537] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | IC50 | 5.42 [uM] | | BioAssay | Fluorescence-based cell-based high throughput dose response assay for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) | | AID | 651553 | | BioAssay type | confirmatory | | Target | RIPK2 gene product [Homo sapiens] [gi:4506537] | | PubMed | | | Data Table |  |
|
| 13 | [SID85147392] | Active | IC50 | 5.42 | Fluorescence-based cell-based high throughput dose response assay for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) [AID651553, Type: confirmatory] | RIPK2 gene product [Homo sapiens] [gi:4506537] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | IC50 | 5.42 [uM] | | BioAssay | Fluorescence-based cell-based high throughput dose response assay for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2) | | AID | 651553 | | BioAssay type | confirmatory | | Target | RIPK2 gene product [Homo sapiens] [gi:4506537] | | PubMed | | | Data Table |  |
|
| 14 | [SID85147392] | Active | AC50 | 6 | Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_Dose_CherryPick_Activity [AID588764, Type: confirmatory] | hypothetical protein CaO19.7491 [Candida albicans SC5314] [gi:68474550] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | AC50 | 6 [uM] | | BioAssay | Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_Dose_CherryPick_Activity | | AID | 588764 | | BioAssay type | confirmatory | | Target | hypothetical protein CaO19.7491 [Candida albicans SC5314] [gi:68474550] | | PubMed | | | Data Table |  |
|
| 15 | [SID131281810] | Active | IC50 | 6.5 | Inhibition of human recombinant MIF tautomerase activity using 4-hydroxyphenylpyruvate as substrate [AID609134, Type: Literature] | Macrophage migration inhibitory factor [gi:1170955] |   View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 131281810 | | CID | 25181243 | | Outcome | Active | | IC50 | 6.5 [uM] | | BioAssay | Inhibition of human recombinant MIF tautomerase activity using 4-hydroxyphenylpyruvate as substrate | | AID | 609134 | | BioAssay type | Literature | | Target | Macrophage migration inhibitory factor [gi:1170955] | | PubMed | 21719283 | | Data Table |  |
|
| 16 | [SID85147392] | Active | Potency | 6.7456 | qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase [AID485367, Type: confirmatory] | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | Potency | 6.7456 [uM] | | BioAssay | qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase | | AID | 485367 | | BioAssay type | confirmatory | | Target | ATP-dependent phosphofructokinase [Trypanosoma brucei] [gi:72386991] | | PubMed | | | Data Table |  |
|
| 17 | [SID85147392] | Active | Potency | 8.9125 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 18 | [SID131281810] | Active | IC50 | 9.1 | Inhibition of human purified PMM2 [AID597375, Type: Literature] | Phosphomannomutase 2 [gi:3024413] |   View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 131281810 | | CID | 25181243 | | Outcome | Active | | IC50 | 9.1 [uM] | | BioAssay | Inhibition of human purified PMM2 | | AID | 597375 | | BioAssay type | Literature | | Target | Phosphomannomutase 2 [gi:3024413] | | PubMed | 21539312 | | Data Table |  |
|
| 19 | [SID131281810] | Active | IC50 | 9.1 | Inhibition of human purified PMM2 [AID597375, Type: Literature] | Phosphomannomutase 2 [gi:3024413] |   View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 131281810 | | CID | 25181243 | | Outcome | Active | | IC50 | 9.1 [uM] | | BioAssay | Inhibition of human purified PMM2 | | AID | 597375 | | BioAssay type | Literature | | Target | Phosphomannomutase 2 [gi:3024413] | | PubMed | 21539312 | | Data Table |  |
|
| 20 | [SID57287680] | Active | IC50 | 9.11 | Counter screen SAR assay for PMM2 inhibitors via a fluorescence intensity assay [AID1655, Type: confirmatory] | phosphomannomutase 2 [Homo sapiens] [gi:4557839] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 57287680 | | CID | 25181243 | | Outcome | Active | | IC50 | 9.11 [uM] | | BioAssay | Counter screen SAR assay for PMM2 inhibitors via a fluorescence intensity assay | | AID | 1655 | | BioAssay type | confirmatory | | Target | phosphomannomutase 2 [Homo sapiens] [gi:4557839] | | PubMed | | | Data Table |  |
|
| 21 | [SID57287680] | Active | IC50 | 9.11 | Counter screen SAR assay for PMM2 inhibitors via a fluorescence intensity assay [AID1655, Type: confirmatory] | phosphomannomutase 2 [Homo sapiens] [gi:4557839] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 57287680 | | CID | 25181243 | | Outcome | Active | | IC50 | 9.11 [uM] | | BioAssay | Counter screen SAR assay for PMM2 inhibitors via a fluorescence intensity assay | | AID | 1655 | | BioAssay type | confirmatory | | Target | phosphomannomutase 2 [Homo sapiens] [gi:4557839] | | PubMed | | | Data Table |  |
|
| 22 | [SID85147392] | Active | Potency | 10 | qHTS for Inhibitors of Cell Surface uPA Generation [AID540303, Type: confirmatory] | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for Inhibitors of Cell Surface uPA Generation | | AID | 540303 | | BioAssay type | confirmatory | | Target | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] | | PubMed | | | Data Table |  |
|
| 23 | [SID85147392] | Active | Potency | 10 | qHTS for Inhibitors of Cell Surface uPA Generation [AID540303, Type: confirmatory] | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS for Inhibitors of Cell Surface uPA Generation | | AID | 540303 | | BioAssay type | confirmatory | | Target | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] | | PubMed | | | Data Table |  |
|
| 24 | [SID85147392] | Active | Potency | 10 | qHTS Assay for Inhibitors of the HIV-1 protein Vpr [AID651644, Type: confirmatory] | Vpr [Human immunodeficiency virus 1] [gi:28872817] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Inhibitors of the HIV-1 protein Vpr | | AID | 651644 | | BioAssay type | confirmatory | | Target | Vpr [Human immunodeficiency virus 1] [gi:28872817] | | PubMed | | | Data Table |  |
|
| 25 | [SID85147392] | Active | IC50 | 10.8 | Dose Response confirmation of small molecule APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay [AID504719, Type: confirmatory] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | IC50 | 10.8 [uM] | | BioAssay | Dose Response confirmation of small molecule APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay | | AID | 504719 | | BioAssay type | confirmatory | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 26 | [SID85147392] | Active | Potency | 11.2202 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 27 | [SID85147392] | Active | Potency | 25.1189 | qHTS for Inhibitors of ATXN expression [AID651635, Type: confirmatory] | ATXN2 gene product [Homo sapiens] [gi:171543895] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS for Inhibitors of ATXN expression | | AID | 651635 | | BioAssay type | confirmatory | | Target | ATXN2 gene product [Homo sapiens] [gi:171543895] | | PubMed | | | Data Table |  |
|
| 28 | [SID85147392] | Active | IC50 | 45.21 | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Primary and Confirmatory Screens [AID624330, Type: confirmatory] | RACGAP1 gene product [Homo sapiens] [gi:21361397] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | IC50 | 45.21 [uM] | | BioAssay | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Primary and Confirmatory Screens | | AID | 624330 | | BioAssay type | confirmatory | | Target | RACGAP1 gene product [Homo sapiens] [gi:21361397] | | PubMed | | | Data Table |  |
|
| 29 | [SID85147392] | Active | CC50 | 100 | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - HeLa Cytotoxicity [AID624300, Type: confirmatory] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | CC50 | 100 [uM] | | BioAssay | Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - HeLa Cytotoxicity | | AID | 624300 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID85147392] | Active | Potency | | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) [AID652105, Type: confirmatory] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K) | | AID | 652105 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID85147392] | Active | | | HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies [AID588358, Type: screening] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | BioAssay | HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies | | AID | 588358 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID85147392] | Active | | | Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line [AID463079, Type: screening] | |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | BioAssay | Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line | | AID | 463079 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 33 | [SID85147392] | Active | | | Counterscreen for IDE inhibitors: Luminescence-based cell-based high throughput assay to identify cytotoxic compounds using HEK cells [AID449730, Type: screening] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | BioAssay | Counterscreen for IDE inhibitors: Luminescence-based cell-based high throughput assay to identify cytotoxic compounds using HEK cells | | AID | 449730 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID85147392] | Active | | | qHTS of D3 Dopamine Receptor Antagonist: qHTS [AID652054, Type: screening] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | BioAssay | qHTS of D3 Dopamine Receptor Antagonist: qHTS | | AID | 652054 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID85147392] | Active | | | uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay [AID504690, Type: screening] | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay | | AID | 504690 | | BioAssay type | screening | | Target | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase [Plasmodium berghei] [gi:12381848] | | PubMed | | | Data Table |  |
|
| 36 | [SID85147392] | Active | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 37 | [SID85147392] | Active | | | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization [AID651674, Type: screening] | HNF4A gene product [Homo sapiens] [gi:31077205] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization | | AID | 651674 | | BioAssay type | screening | | Target | HNF4A gene product [Homo sapiens] [gi:31077205] | | PubMed | | | Data Table |  |
|
| 38 | [SID85147392] | Active | | | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization [AID651674, Type: screening] | HNF4A gene product [Homo sapiens] [gi:31077205] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization | | AID | 651674 | | BioAssay type | screening | | Target | HNF4A gene product [Homo sapiens] [gi:31077205] | | PubMed | | | Data Table |  |
|
| 39 | [SID85147392] | Active | | | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization [AID651674, Type: screening] | HNF4A gene product [Homo sapiens] [gi:31077205] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5): Luminescence-based biochemical high throughput assay to identify inhibitors of Hepatocyte nuclear factor 4 (HNF4) dimerization | | AID | 651674 | | BioAssay type | screening | | Target | HNF4A gene product [Homo sapiens] [gi:31077205] | | PubMed | | | Data Table |  |
|
| 40 | [SID85147392] | Active | | | Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE) [AID434962, Type: screening] | IDE gene product [Homo sapiens] [gi:155969707] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | BioAssay | Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE) | | AID | 434962 | | BioAssay type | screening | | Target | IDE gene product [Homo sapiens] [gi:155969707] | | PubMed | | | Data Table |  |
|
| 41 | [SID85147392] | Active | | | Fluorescence polarization-based cell-based high throughput confirmation assay for inhibitors of insulin-degrading enzyme (IDE) [AID435028, Type: screening] | IDE gene product [Homo sapiens] [gi:155969707] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | BioAssay | Fluorescence polarization-based cell-based high throughput confirmation assay for inhibitors of insulin-degrading enzyme (IDE) | | AID | 435028 | | BioAssay type | screening | | Target | IDE gene product [Homo sapiens] [gi:155969707] | | PubMed | | | Data Table |  |
|
| 42 | [SID85147392] | Active | | | Single concentration confirmation of inhibitors of Sentrin-specific proteases (SENPs) using a Caspase-3 Selectivity assay [AID488918, Type: screening] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Sentrin-specific proteases (SENPs) using a Caspase-3 Selectivity assay | | AID | 488918 | | BioAssay type | screening | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 43 | [SID85147392] | Active | | | Single concentration confirmation of inhibitors of Sentrin-specific proteases (SENPs) using a Caspase-3 Selectivity assay [AID488918, Type: screening] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Sentrin-specific proteases (SENPs) using a Caspase-3 Selectivity assay | | AID | 488918 | | BioAssay type | screening | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 44 | [SID85147392] | Active | | | Single concentration confirmation of inhibitors of Sentrin-specific proteases (SENPs) using a Caspase-3 Selectivity assay [AID488918, Type: screening] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Sentrin-specific proteases (SENPs) using a Caspase-3 Selectivity assay | | AID | 488918 | | BioAssay type | screening | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 45 | [SID85147392] | Active | | | Single concentration confirmation of inhibitors of Sentrin-specific proteases (SENPs) using a Caspase-3 Selectivity assay [AID488918, Type: screening] | CASP3 gene product [Homo sapiens] [gi:14790119] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Sentrin-specific proteases (SENPs) using a Caspase-3 Selectivity assay | | AID | 488918 | | BioAssay type | screening | | Target | CASP3 gene product [Homo sapiens] [gi:14790119] | | PubMed | | | Data Table |  |
|
| 46 | [SID85147392] | Active | | | uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 7 (SENP7) [AID434973, Type: screening] | SUMO1/sentrin specific peptidase 7 [Homo sapiens] [gi:120538355] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | BioAssay | uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 7 (SENP7) | | AID | 434973 | | BioAssay type | screening | | Target | SUMO1/sentrin specific peptidase 7 [Homo sapiens] [gi:120538355] | | PubMed | | | Data Table |  |
|
| 47 | [SID85147392] | Active | | | Single concentration confirmation of uHTS for inhibitors of Sentrin-specific protease 7 (SENP7) using a Luminescent assay [AID488917, Type: screening] | SUMO1/sentrin specific peptidase 7 [Homo sapiens] [gi:120538355] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS for inhibitors of Sentrin-specific protease 7 (SENP7) using a Luminescent assay | | AID | 488917 | | BioAssay type | screening | | Target | SUMO1/sentrin specific peptidase 7 [Homo sapiens] [gi:120538355] | | PubMed | | | Data Table |  |
|
| 48 | [SID85147392] | Active | | | uHTS Colorimetric assay for identification of inhibitors of Scp-1 [AID493091, Type: screening] | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | BioAssay | uHTS Colorimetric assay for identification of inhibitors of Scp-1 | | AID | 493091 | | BioAssay type | screening | | Target | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] | | PubMed | | | Data Table |  |
|
| 49 | [SID85147392] | Active | | | uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 6 (SENP6) [AID2599, Type: screening] | SUMO-1-specific protease [Homo sapiens] [gi:6166485] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | BioAssay | uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 6 (SENP6) | | AID | 2599 | | BioAssay type | screening | | Target | SUMO-1-specific protease [Homo sapiens] [gi:6166485] | | PubMed | | | Data Table |  |
|
| 50 | [SID85147392] | Active | | | Single concentration confirmation of uHTS for inhibitors of Sentrin-specific protease 6 (SENP6) using a Luminescent assay [AID488915, Type: screening] | SUMO-1-specific protease [Homo sapiens] [gi:6166485] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 85147392 | | CID | 25181243 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS for inhibitors of Sentrin-specific protease 6 (SENP6) using a Luminescent assay | | AID | 488915 | | BioAssay type | screening | | Target | SUMO-1-specific protease [Homo sapiens] [gi:6166485] | | PubMed | | | Data Table |  |
|